Overexpression of constitutively active Akt significantly reverses the inhibitory effects of propofol in K562, confirm that propofol acts on CML cells via inhibition of Akt/mTOR. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.